<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu CM</submitter><funding>NIDDK NIH HHS</funding><pagination>00137-2024</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11726580</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Chronic rhinosinusitis (CRS) and olfactory dysfunction (OD) are prevalent disease complications in people with cystic fibrosis. These understudied comorbidities significantly impact quality of life. The impact of highly effective modulator therapy (HEMT) in young children with cystic fibrosis (YCwCF) on these disease complications is unknown. This proposed study aims to characterise CRS and OD in YCwCF and assess the efficacy of HEMT in improving sinus and olfactory health in this young age group.&lt;h4>Methods&lt;/h4>This six-centre, prospective, observational study will enrol 80 YCwCF aged 2-8 years. Patients are divided into two groups: those receiving HEMT and those not on HEMT based on clinical indication. Both groups undergo sinus magnetic resonance imaging, psychophysic</pubmed_abstract><journal>ERJ open research</journal><pubmed_title>The impact of highly effective modulator therapy on sinusitis and dysosmia in young children with cystic fibrosis: a prospective study protocol.</pubmed_title><pmcid>PMC11726580</pmcid><funding_grant_id>P30 DK089507</funding_grant_id><pubmed_authors>Hoffman LR</pubmed_authors><pubmed_authors>Froh D</pubmed_authors><pubmed_authors>Lewis M</pubmed_authors><pubmed_authors>Milla SS</pubmed_authors><pubmed_authors>Woods JC</pubmed_authors><pubmed_authors>Sullivan JS</pubmed_authors><pubmed_authors>Sawatzky BD</pubmed_authors><pubmed_authors>Ode KL</pubmed_authors><pubmed_authors>Heltshe SL</pubmed_authors><pubmed_authors>Goss CH</pubmed_authors><pubmed_authors>Fischer JL</pubmed_authors><pubmed_authors>Taylor-Cousar JL</pubmed_authors><pubmed_authors>Beswick DM</pubmed_authors><pubmed_authors>Sim MS</pubmed_authors><pubmed_authors>Kramer EL</pubmed_authors><pubmed_authors>Niedbalski PJ</pubmed_authors><pubmed_authors>Zemanick ET</pubmed_authors><pubmed_authors>Mata J</pubmed_authors><pubmed_authors>Trout AT</pubmed_authors><pubmed_authors>Markarian KK</pubmed_authors><pubmed_authors>Fain SB</pubmed_authors><pubmed_authors>Humphries SM</pubmed_authors><pubmed_authors>Liu CM</pubmed_authors><pubmed_authors>Li DA</pubmed_authors></additional><is_claimable>false</is_claimable><name>The impact of highly effective modulator therapy on sinusitis and dysosmia in young children with cystic fibrosis: a prospective study protocol.</name><description>&lt;h4>Background&lt;/h4>Chronic rhinosinusitis (CRS) and olfactory dysfunction (OD) are prevalent disease complications in people with cystic fibrosis. These understudied comorbidities significantly impact quality of life. The impact of highly effective modulator therapy (HEMT) in young children with cystic fibrosis (YCwCF) on these disease complications is unknown. This proposed study aims to characterise CRS and OD in YCwCF and assess the efficacy of HEMT in improving sinus and olfactory health in this young age group.&lt;h4>Methods&lt;/h4>This six-centre, prospective, observational study will enrol 80 YCwCF aged 2-8 years. Patients are divided into two groups: those receiving HEMT and those not on HEMT based on clinical indication. Both groups undergo sinus magnetic resonance imaging, psychophysic</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-07-15T11:11:55.028Z</modification><creation>2026-07-05T03:08:24.46Z</creation></dates><accession>S-EPMC11726580</accession><cross_references><pubmed>39811548</pubmed><doi>10.1183/23120541.00137-2024</doi></cross_references></HashMap>